As of close of business last night, DocGo Inc’s stock clocked out at $3.79, down -1.56% from its previous closing price of $3.85. In other words, the price has decreased by -$0.0600 from its previous closing price. On the day, 795267 shares were traded. DCGO stock price reached its highest trading level at $3.8875 during the session, while it also had its lowest trading level at $3.7600.
Ratios:
To gain a deeper understanding of DCGO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.99 and its Current Ratio is at 1.99. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $15.
On April 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
On April 19, 2022, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $11.Deutsche Bank initiated its Buy rating on April 19, 2022, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 28 ’23 when Sugrue Stephen sold 2,859 shares for $5.75 per share. The transaction valued at 16,439 led to the insider holds 32,257 shares of the business.
Bienstock Lee sold 1,667 shares of DCGO for $9,819 on Oct 16 ’23. The Chief Executive Officer now owns 299,037 shares after completing the transaction at $5.89 per share. On Oct 02 ’23, another insider, Tendler Ely D, who serves as the General Counsel and Secretary of the company, sold 10,000 shares for $5.29 each. As a result, the insider received 52,900 and left with 23,088 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 401.06M and an Enterprise Value of 388.27M. As of this moment, DocGo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 58.40, and their Forward P/E ratio for the next fiscal year is 8.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.63 while its Price-to-Book (P/B) ratio in mrq is 1.31. Its current Enterprise Value per Revenue stands at 0.62 whereas that against EBITDA is 12.33.
Stock Price History:
The Beta on a monthly basis for DCGO is 0.91, which has changed by -55.75% over the last 52 weeks, in comparison to a change of 30.58% over the same period for the S&P500. Over the past 52 weeks, DCGO has reached a high of $10.82, while it has fallen to a 52-week low of $2.78. The 50-Day Moving Average of the stock is 3.8628, while the 200-Day Moving Average is calculated to be 6.5015.
Shares Statistics:
It appears that DCGO traded 1.66M shares on average per day over the past three months and 1.54M shares per day over the past ten days. A total of 104.06M shares are outstanding, with a floating share count of 86.92M. Insiders hold about 16.57% of the company’s shares, while institutions hold 47.39% stake in the company. Shares short for DCGO as of Feb 15, 2024 were 9.84M with a Short Ratio of 5.93, compared to 8.5M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.46% and a Short% of Float of 10.84%.
Earnings Estimates
As of right now, 7 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.05, while EPS last year was -$0.03. The consensus estimate for the next quarter is $0.08, with high estimates of $0.11 and low estimates of $0.06.
Analysts are recommending an EPS of between $0.46 and $0.25 for the fiscal current year, implying an average EPS of $0.34. EPS for the following year is $0.47, with 5 analysts recommending between $0.58 and $0.34.
Revenue Estimates
In the current quarter, 7 analysts expect revenue to total $187.93M. It ranges from a high estimate of $202.9M to a low estimate of $181.52M. As of the current estimate, DocGo Inc’s year-ago sales were $111.53M, an estimated increase of 68.50% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $185.29M, an increase of 47.70% less than the figure of $68.50% in the same quarter last year. There is a high estimate of $206.3M for the next quarter, whereas the lowest estimate is $172.6M.
A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $803.6M, while the lowest revenue estimate was $728.2M, resulting in an average revenue estimate of $745.2M. In the same quarter a year ago, actual revenue was $624.29M, up 19.40% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $809.07M in the next fiscal year. The high estimate is $834.1M and the low estimate is $761M. The average revenue growth estimate for next year is up 8.60% from the average revenue estimate for this year.
